Press Release

Cooley Advises Medidata Solutions on Agreement to Acquire Shyft

July 26, 2018

Palo Alto – July 26, 2018 – Cooley recently advised Medidata Solutions on its definitive agreement to acquire Shyft Analytics, a leading cloud data platform for life sciences. Partner Jon Gavenman led the Cooley team advising Medidata.

According to Medidata, the combined platform seamlessly delivers market-leading applications, services and proven data science capabilities, powered by the largest global pool of research data, companies’ own CRM data, third-party commercial data and real-world data sources.

Medidata’s unified platform, pioneering analytics and unrivaled expertise power the development of new therapies for more than 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. 

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.